Intelligence · Clinical Pipeline
Gilead Sciences Ireland Pipeline
All ClinicalTrials.gov programs at Gilead Sciences Ireland — phase, modality, and trial IDs.
- Programs
- 13
Quick answer
Gilead Sciences Ireland has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AZLI 75 mg two times a day (BID)/ three times a day (TID)
Gilead Sciences Ireland UC
Cystic Fibrosis
1 trial -
B/F/TAF
Gilead Sciences Ireland UC
HIV-1/HBV Co-Infection
1 trial -
B/F/TAF (Adult Strength)
Gilead Sciences Ireland UC
HIV-1 Infection
1 trial -
Bictegravir
Gilead Sciences Ireland UC
HIV-1-infection
2 trials -
COBI
Gilead Sciences Ireland UC
HIV
1 trial -
E/C/F/TDF
Gilead Sciences Ireland UC
Acquired Immunodeficiency Syndrome
1 trial -
LDV/SOF
Gilead Sciences Ireland UC
Hepatitis C Virus
1 trial -
SOF/VEL
Gilead Sciences Ireland UC
Hepatitis C Virus Infection
3 trials -
SOF/VEL/VOX
Gilead Sciences Ireland UC
Hepatitis C Virus Infection
1 trial -
Sacituzumab Govitecan-hziy
Gilead Sciences Ireland UC
Triple Negative Breast Cancer
1 trial -
Sofosbuvir
Gilead Sciences Ireland UC
Chronic HCV Infection
1 trial -
Sofosbuvir
Gilead Sciences Ireland UC
Hepatitis C
2 trials -
Tenofovir DF
Gilead Sciences Ireland UC
Chronic Hepatitis B
1 trial
Frequently asked questions
How many pipeline programs does Gilead Sciences Ireland have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs